Alcon AG presented an overview of its recent performance and strategic direction at the J.P. Morgan Healthcare Conference. The company reported $9.8 billion in sales for 2024 and $7.6 billion for the year-to-date period ending in the third quarter of 2025. Alcon highlighted its leading position in the global surgical equipment market and its broad portfolio of ocular health products and contact lenses, serving customers in over 140 countries. The presentation outlined the company’s focus on advancing eye care through research, product development, and training programs. Alcon detailed innovations in ophthalmic surgery, including next-generation devices and a comprehensive surgical ecosystem designed to support clinics, cloud-based planning, and operating room integration. The company also discussed the steady growth in global cataract surgery volumes, which have increased in line with the aging population. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alcon AG published the original content used to generate this news brief on January 13, 2026, and is solely responsible for the information contained therein.